Melanoma targeted NGS panel-Pathology add-on

Test info

  
Melanoma targeted NGS panel
  
Pathology add-on
  
FOCUS
  
Hot spot mutations
Next Generation Sequencing
Oncomine focus assay
  
  • BRAF
  • KIT
  • NRAS
  • GNA11
  • GNAQ
  

Next Generation Sequencing (NGS) for the detection of alterations in solid tumors is critical for cancer care as these findings can direct the optimal use of targeted therapies for patients.

  

If blocks more than 5 years old are submitted for testing, extraction will be attempted, but if insufficient RNA/DNA is retrieved, testing will be cancelled

Specimen

  
Tumor tissue
  

Formalin-fixed paraffin-embedded (FFPE) tissue block

  

Cytology slide

  

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

  

Ambient

Performance

  
AHL - Molecular Diagnostics: D
  
Varies
  
10 business days
  

Next Generation Sequencing

Clinical and Interpretive info

  

No variations detected

Billing

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81445 - NGS: targeted genomic sequence analysis panel, solid organ 5 - 50 genes
  
Yes
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

Molecular Medicare billing request

Tracking

  
12/08/2020
  
05/15/2024
  
01/15/2024